Inventor · disambiguated record
Indresh Srivastava
Also filed as: SRIVASTAVA INDRESH · SRIVASTAVA INDRESH K
10 granted patents·17 pending applications·22 citations·filing 2001–2021
84Inventor score
Top patents by PatentIndex Score
27 records- 0184US7811580B2Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Oct 12, 2010·9 cites·24 claims
- 0281US8197819B2Env polypeptide complexes and methods of useSRIVASTAVA INDRESH K·Filed 2005·Granted Jun 12, 2012·8 cites·10 claims
- 0377US8206720B2Fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutraliziation epitopesMASIGNANI VEGA·Filed 2005·Granted Jun 26, 2012·2 cites·12 claims
- 0474US8168418B2Expression of HIV polypeptides and production of virus-like particlesBARNETT SUSAN W·Filed 2010·Granted May 1, 2012·2 cites·14 claims
- 0573US7718401B2Expression of HIV polypeptides and production of virus-like particlesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2008·Granted May 18, 2010·0 cites·10 claims
- 0672US2009081254A1Hiv vaccine for mucosal deliveryNOVARTIS VACCINES & DIAGNOSTIC·Filed 2008·Application pending·0 cites
- 0771US2009208530A1HIV polynucleotides and polypeptides derived from Botswana MJ4LIAN YING·Filed 2009·Application pending·0 cites
- 0868US8568734B2Method for generating immune responses utilizing nucleic acids encoding fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopesMASIGNANI VEGA·Filed 2012·Granted Oct 29, 2013·1 cites·13 claims
- 0962US2008300385A1Covalently-linked complexes of HIV Tat and Env proteinsSHARMA VICTORIA·Filed 2007·Application pending·0 cites
- 1061US2007073048A1Hiv polynucleotides and polypeptides derived from botswana mj4LIAN YING·Filed 2004·Application pending·0 cites
- 1159US8470334B2Method of inducing an antiviral immune response against HIV-1 utilizing chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimeticsBARNETT SUSAN W·Filed 2012·Granted Jun 25, 2013·0 cites·28 claims
- 1259US2005175631A1Hiv vaccine and method of useFiled 2003·Application pending·0 cites
- 1359US2012269840A1Expression of hiv polypeptides and production of virus-like particlesBARNETT SUSAN W·Filed 2012·Application pending·0 cites
- 1456US2011052632A1Hiv polynucleotides and polypeptides derived from botswana mj4NOVARTIS VACCINES & DIAGNOSTIC·Filed 2010·Application pending·0 cites
- 1555US8226955B2Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopesBARNETT SUSAN W·Filed 2010·Granted Jul 24, 2012·0 cites·15 claims
- 1653US2011045017A1Hiv vaccine for mucosal deliveryNOVARTIS VACCINES & DIAGNOSTIC·Filed 2010·Application pending·0 cites
- 1752US2011257377A1Covalently linked complexes of HIV TAT and ENV PROTEINSBARNETT SUSAN W·Filed 2007·Application pending·0 cites
- 1852US2024269270A1Covid-19 vaccines with tocopherol-containing squalene emulsion adjuvantsSANOFI PASTEUR INC·Filed 2021·Application pending·0 cites
- 1952US2011110977A1Multiclade HIV VaccinesBARNETT SUSAN W·Filed 2006·Application pending·0 cites
- 2051US2007166784A1Combination approaches for generating immune responsesBARNETT SUSAN W·Filed 2004·Application pending·0 cites
- 2150US8637044B2Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopesBARNETT SUSAN·Filed 2012·Granted Jan 28, 2014·0 cites·20 claims
- 2250US8168194B2Fusion proteins comprising CD4 minimal modules and human immunodeficiency virus (HIV) Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopesBARNETT SUSAN·Filed 2006·Granted May 1, 2012·0 cites·15 claims
- 2349US2024016918A1Vaccines against sars-cov-2 infectionsSANOFI PASTEUR INC·Filed 2021·Application pending·0 cites
- 2447US2013315955A1Stability and potency of hemagglutininHOLTZ KATHLEEN·Filed 2013·Application pending·0 cites
- 2545US2012276141A1Env polypeptide complexes and methods of useSRIVASTAVA INDRESH K·Filed 2012·Application pending·0 cites
- 2643US2015183835A1Stabilized gp120NOVARTIS AG·Filed 2013·Application pending·0 cites
- 2739US2002127238A1HIV-1 vaccines and screening methods thereforFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Indresh Srivastava files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →